Modulation of Anthracycline-Induced Myofibrillar Disarray in Rat Ventricular Myocytes by Neuregulin-1β and Anti-erbB2-Reference-Cited by-同舟云学术

Modulation of Anthracycline-Induced Myofibrillar Disarray in Rat Ventricular Myocytes by Neuregulin-1β and Anti-erbB2

Published:2002-04-02 Issue:13 Volume:105 Page:1551-1554
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Sawyer Douglas B.¹,Zuppinger Christian¹,Miller Thomas A.¹,Eppenberger Hans M.¹,Suter Thomas M.¹

Affiliation:

1. From the Cardiovascular Medicine Section, Department of Medicine, Boston Medical Center and Myocardial Biology Unit, Boston University School of Medicine, Boston, Mass (D.B.S., T.A.M.), and the Institute of Cell Biology, Swiss Federal Institute of Technology, Zurich, and Swiss Cardiovascular Center Bern, Inselspital, Bern, Switzerland (C.Z., H.M.E., T.M.S.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference17 articles.

1. Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

2. Requirement for neuregulin receptor erbB2 in neural and cardiac development

3. Multiple essential functions of neuregulin in development

4. Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor

5. Neuregulins Promote Survival and Growth of Cardiac Myocytes

Cited by 262 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trastuzumab-Induced Cardiotoxicity: When and How Much Should We Worry?;JCO Oncology Practice;2024-08

2. An update of the molecular mechanisms underlying anthracycline induced cardiotoxicity;Frontiers in Pharmacology;2024-06-26

3. Novel insights into cardiovascular toxicity of cancer targeted and immune therapies: Beyond ischemia with non-obstructive coronary arteries (INOCA);American Heart Journal Plus: Cardiology Research and Practice;2024-04

4. Cardiotoxic Drugs: An Insight into its Pathologic Mechanisms;Biosciences Biotechnology Research Asia;2024-03-30

5. The Role of Doxorubicin in the Formation of Cardiotoxicity – Generally Accepted Statement. Part I. Prevalence and Mechanisms of Formation (Review);Drug development & registration;2024-01-19